Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.25
Bid: 15.50
Ask: 17.00
Change: -0.25 (-1.52%)
Spread: 1.50 (9.677%)
Open: 16.50
High: 16.50
Low: 16.25
Prev. Close: 16.50
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Card Factory profit climbs; Pebble "consistent"

Tue, 30th Apr 2024 15:56

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Sorted Group Holdings PLC - Cheltenham, England-based location data verification company - Receives about GBP2.0 million in research and development tax credits from HMRC. The R&D tax credit relates to Sorted Group Ltd's claim made to HMRC in respect of the financial year ended September 30, 2022.

----------

Northamber PLC - London-based distributor of audio-visual and information technology equipment - Buys Tempura Technology Ltd and Tempura Communications Ltd from Matthew Light. "Tempura is a value-add distributor of unified communications including VoIP, connectivity, audio visual and video conferencing solutions in the UK, Ireland and the BeNeLux," Northamber says. Located in Basingstoke, Tempura also has premises in Dublin and the Netherlands. The total payment for the acquisition is GBP6.0 million. In year ended June 30, Tempura reported revenue of GBP14.6 million and pretax profit of GBP810,000. Chair Alex Phillips says: "The board believes that there is significant opportunity for further suitable acquisitions in the sector, which should generate additional value for Northamber's shareholders in the medium term."

----------

Gowin New Energy Group Ltd - China-based LED lighting products and tea trading - Chief Executive Officer Chen Chih-Lung gives GBP20,000 loan. Interest on loan is payable at 2% per annum rate and is repayable in 12 months. "The purpose of the loan is to provide short term liquidity to allow the company to satisfy its payment obligations," Gowin says.

----------

OptiBiotix Health PLC - York, England-based life sciences company - Says its wholly owned Indian subsidiary, OptiBiotix Health India Private Ltd, has signed a manufacturing agreement with KAG Industries for the supply of Slimbiome containing products ready for sale. Says KAG have developed five flavours "unique to the Indian market." Adds that "KAG is a specialised contract manufacturer of nutritional powders with its own research and development laboratories allowing it to create customised finished products for its clients."

----------

Pebble Group PLC - Manchester, England-based provider of products and services to the global promotional products industry - Says in year-to-date, financial performance has been "consistent" with same period in 2023. Looking ahead, says trading at Facilisgroup and Brand Addition is progressing in line with the delivery of full year market expectations. "The board continues to see attractive opportunities for both Facilisgroup and Brand Addition and we remain focused on executing our plan for 2024 and beyond," it adds. In a separate announcement, says Richard Law has resigned as chair. CEO Chris Lee to take short-term interim chair role, alongside current duties. Pebble says: "The board would like to thank Richard for his input and counsel and for supporting the teams in developing and implementing the group's strategies and growth plans since its IPO in 2019. "

----------

Card Factory PLC - Wakefield, West Yorkshire-based greeting cards and gifting firm - Reports results for financial year ended January 31. Revenue climbs 10% to GBP510.9 million from GBP463.4 million a year earlier. Pretax profit jumps 25% to GBP65.6 million from GBP52.4 million. Pays out dividend of 4.5p, up from no dividend a year ago. Looking ahead, Card Factory remains "confident in the long-term compelling growth opportunity" for the company, and in its ability to deliver on the medium-term targets of GBP650 million of sales, pretax profit margins of 14% and 90 net new stores by the end of FY27. Adds that pretax profit growth in financial 2025 is expected to be weighted toward the second half of the year "due to the phasing of planned investment and inflationary recovery actions."

----------

Sealand Capital Galaxy Ltd - Asia-focused digital investor that offers financial and strategic support to entrepreneurs - Revenue in 2023 falls to GBP125,793 from GBP226,750 a year earlier. Pretax loss widens to GBP427,046 from GBP179,569. Chair Nelson Law says: "Despite the global economy experiencing sluggish growth in the aftermath of the pandemic, the group remains dedicated to enhancing its performance. However, the group acknowledges the challenges posed by ongoing political conflicts between nations. Nevertheless, the group is steadfast in the belief that the group can expand our sales within our region, employing a strategic approach that emphasizes the expansion of direct sales through online shopping platforms."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
17 Apr 2020 14:35

OptiBiotix Health Raises GBP1 Million Through Share Issue

OptiBiotix Health Raises GBP1 Million Through Share Issue

Read more
6 Apr 2020 16:40

OptiBiotix Signs SlimBiome Manufacturing Deal With Laboratoire PYC

OptiBiotix Signs SlimBiome Manufacturing Deal With Laboratoire PYC

Read more
6 Apr 2020 16:17

OptiBiotix enters manufacturing deal with France's Laboratoire PYC

(Sharecast News) - Life sciences company OptiBiotix Health has entered into a contract manufacturing agreement with Laboratoire PYC in France, it announced on Monday.

Read more
2 Apr 2020 13:35

OptiBiotix enters manufacturing deal with Denmark's Fipros

(Sharecast News) - Life sciences company OptiBiotix Health has entered into a contract manufacturing agreement with Fipros in Denmark, it announced on Thursday.

Read more
2 Apr 2020 12:29

OptiBiotix Health Signs SlimBiome Manufacturing Agreement With Fipros

OptiBiotix Health Signs SlimBiome Manufacturing Agreement With Fipros

Read more
31 Mar 2020 16:32

OptiBiotix shares soar on new deal with OptiPharm

(Sharecast News) - Life science company OptiBiotix Health has entered into an exclusive licence agreement for the use of its 'OptiBiome' weight management ingredient, it announced on Tuesday, with OptiPharm.

Read more
31 Mar 2020 15:55

OptiBiotix Licences OptiBiome Weight Loss Ingredient To OptiPharm

OptiBiotix Licences OptiBiome Weight Loss Ingredient To OptiPharm

Read more
24 Mar 2020 16:09

OptiBiotix Expands GoFigure Sales Across Eastern Europe, Central Asia

OptiBiotix Expands GoFigure Sales Across Eastern Europe, Central Asia

Read more
24 Mar 2020 09:02

OptiBiotix expands distribution deal with Extensor

(Sharecast News) - Life sciences business OptiBiotix Health has extended the territories of its original distribution agreements with Extensor Robert Buczek to distribute its own-label 'GoFigure' consumer weight management products in Ukraine, Estonia, Lithuania, Latvia, Kazakhstan, Kyrgyzstan, Tajikistan, Uzbekistan, Turkmenistan, Armenia, Azerbaijan, Georgia, Belarus, Moldova and Russia, it announced on Tuesday.

Read more
17 Mar 2020 15:49

OptiBiotix Health signs distribution deal in Lebanon

(Sharecast News) - Life sciences business OptiBiotix Health has entered into a one year exclusive distribution agreement with Prosperous Pharma, it announced on Tuesday.

Read more
17 Mar 2020 11:18

OptiBiotix Signs Exclusive Distribution Contract For SlimBiome Medical

OptiBiotix Signs Exclusive Distribution Contract For SlimBiome Medical

Read more
12 Mar 2020 13:24

OptiBiotix's ProBiotix Signs Licensing Agreement With Velinoff Pharma

OptiBiotix's ProBiotix Signs Licensing Agreement With Velinoff Pharma

Read more
11 Mar 2020 15:08

OptiBiotix Health amends agreement with partner Sacco

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary, ProBiotix Health, has signed a new global manufacturing and supply agreement with Sacco to modify and extend their existing relationship through to the end of 2023.

Read more
11 Mar 2020 09:55

OptiBiotix's ProBiotix Extends LPLDL Supply Agreement With Sacco

OptiBiotix's ProBiotix Extends LPLDL Supply Agreement With Sacco

Read more
17 Feb 2020 10:45

OptiBiotix Signs US Distribution Pact For LPLDL Probiotic

OptiBiotix Signs US Distribution Pact For LPLDL Probiotic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.